FDA Alerts on Shortage of Breast Biopsy Needles

(MedPage Today) -- The FDA informed healthcare providers about disruptions in the supply of stereotactic breast biopsy needles that will likely persist through March 2027.
According to the agency, the disruption is expected to impact patient care...